References
- National Cancer Registration Service and A (NCRAS) Main cancer treatments [cited 2018 Mar 7]. Available from: http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/main_cancer_treatments.
- Citrin DE. Recent developments in radiotherapy. N Engl J Med. 2017;377:1065–1075.
- Straub JM, New J, Hamilton CD, et al. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141:1985–1994.
- Zoubek J, McGuire EJ, Noll F, et al. The late occurrence of urinary tract damage in patients successfully treated by radiotherapy for cervical carcinoma. J Urol 1989;141:1347–1349.
- Farquharson DI, Shingleton HM, Soong SJ, et al. The adverse effects of cervical cancer treatment on bladder function. Gynecol Oncol. 1987;27:15–23.
- Goodman M, Dalton JR. Ureteral strictures following radiotherapy: incidence, etiology and treatment guidelines. J Urol. 1982;128:21–24.
- Morris K AL. Pelvic radiation therapy: between delight and disaster. World J Gastrointest Surg. 2015;7:279.
- Liberman D, Mehus B, Elliott SP. Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol. 2014;3:186–195.
- Cancerresearchuk Prostate cancer incidence statistics | Cancer Research UK [cited 2018 Mar 7]. Available from:http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#heading-One.
- Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009;18:1688–1694.
- Eifel PJ, Levenback C, Wharton JT, et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol. 1995;32:1289–1300.
- Maduro JH, Pras E, Willemse PHB, et al. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29:471–488.
- Sung Uk L, Young Ae K, Young-Ho Y, et al. General health status of long-term cervical cancer survivors after radiotherapy. Strahlenther Onkol. 2017;193:543–551.
- Parkin DE, Davis JA, Symonds RP. (Long-term bladder symptomatology following radiotherapy for cervical carcinoma. Radiother Oncol. 1987;9:195–199.
- Maier U, Ehrenböck PM, Hofbauer J. Late urological complications and malignancies after curative radiotherapy for gynecological carcinomas: a retrospective analysis of 10,709 patients. J Urol. 1997;158:814–817.
- Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 1990;19:1569–1574. )
- Kim JH, Jenrow KA, Brown SL. Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J. 2014;32:103–115.
- Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys. 2000;47:27790.
- McIntyre JF, Eifel PJ, Levenback C, et al. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer 1995;75:836–843.
- Gellrich J, Hakenberg OW, Oehlschläger S, et al. Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma. Oncol Res. Treat. 2003;26:334–340.
- Hillary CJ, Osman NI, Hilton P, et al. The Aetiology, treatment, and outcome of urogenital fistulae managed in well- and low-resourced countries: a systematic review. Eur Urol. 2016;70:478–492.
- Pushkar DY, Dyakov VV, Kasyan GR. Management of radiation-induced vesicovaginal fistula. Eur Urol. 2009;55:131–138.
- Hautmann RE, Volkmer BG, Gust K. Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3). World J Urol. 2009;27:347–351.